ATE455775T1 - Makrocyclische inhibitoren des hepatitis-c-virus - Google Patents

Makrocyclische inhibitoren des hepatitis-c-virus

Info

Publication number: ATE455775T1
Authority: AT; Austria
Prior art keywords: hepatitis; virus; macrocyclic inhibitors; macrocyclic; inhibitors
Prior art date: 2005-07-29

Application number

AT06764268T

Other languages

English (en)

Inventor

Pierre Raboisson

Kock Herman De

Lili Hu

Kenneth Simmen

Karin Charlotta Lindquist

Mats Stefan Lindstroem

Anna Karin Gertrud Belfrage

Horst Juergen Waehling

Karl Magnus Nilsson

Bengt Bertil Samuelsson

Asa Annica Kristina Rosenquist

Sven Crister Sahlberg

Hans Wallberg

Pia Kahnberg

Bjoern Classon

Original Assignee

Tibotec Pharm Ltd

Medivir Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-29

Filing date

2006-07-28

Publication date

2010-02-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37708968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE455775(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-07-28 Application filed by Tibotec Pharm Ltd, Medivir Ab filed Critical Tibotec Pharm Ltd

2010-02-15 Application granted granted Critical

2010-02-15 Publication of ATE455775T1 publication Critical patent/ATE455775T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Virology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Plural Heterocyclic Compounds (AREA)

AT06764268T 2005-07-29 2006-07-28 Makrocyclische inhibitoren des hepatitis-c-virus ATE455775T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP05107057		2005-07-29
EP06113097		2006-04-25
PCT/EP2006/064822 WO2007014927A2 (en)	2005-07-29	2006-07-28	Macrocyclic inhibitors of hepatitis c virus

Publications (1)

Publication Number	Publication Date
ATE455775T1 true ATE455775T1 (de)	2010-02-15

Family

ID=37708968

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06764268T ATE455775T1 (de)	2005-07-29	2006-07-28	Makrocyclische inhibitoren des hepatitis-c-virus

Country Status (32)

Country	Link
US (1)	US7659245B2 (de)
EP (1)	EP1912981B1 (de)
JP (1)	JP5230418B2 (de)
KR (1)	KR101083631B1 (de)
AP (1)	AP2585A (de)
AR (1)	AR057702A1 (de)
AT (1)	ATE455775T1 (de)
AU (1)	AU2006274866B2 (de)
BR (1)	BRPI0614153A2 (de)
CA (1)	CA2617103C (de)
CY (1)	CY1110008T1 (de)
DE (1)	DE602006011905D1 (de)
DK (1)	DK1912981T3 (de)
EA (1)	EA014188B1 (de)
ES (1)	ES2339702T3 (de)
GT (1)	GT200600343A (de)
HK (1)	HK1116488A1 (de)
HR (1)	HRP20100209T1 (de)
IL (1)	IL188320A (de)
ME (1)	ME01454B (de)
MY (1)	MY151026A (de)
NO (1)	NO20081075L (de)
NZ (1)	NZ564540A (de)
PE (1)	PE20070343A1 (de)
PL (1)	PL1912981T3 (de)
PT (1)	PT1912981E (de)
RS (1)	RS51227B (de)
SI (1)	SI1912981T1 (de)
SV (1)	SV2008002641A (de)
TW (1)	TWI387597B (de)
UY (1)	UY29704A1 (de)
WO (1)	WO2007014927A2 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY140680A (en)	2002-05-20	2010-01-15	Bristol Myers Squibb Co	Hepatitis c virus inhibitors
EA014584B1 (ru)	2004-01-30	2010-12-30	Медивир Аб	Ингибиторы ns-3 сериновой протеазы hcv
CN101273052B (zh)	2005-07-29	2016-01-13	爱尔兰詹森科学公司	丙型肝炎病毒的大环抑制剂
PE20070211A1 (es)	2005-07-29	2007-05-12	Medivir Ab	Compuestos macrociclicos como inhibidores del virus de hepatitis c
DK1912997T3 (da)	2005-07-29	2012-01-02	Tibotec Pharm Ltd	Makrocycliske inhibitorer af hepatitis C virus
JO2768B1 (en) *	2005-07-29	2014-03-15	تيبوتيك فارماسيوتيكالز ليمتد	Large cyclic inhibitors of hepatitis C virus
DE602006019323D1 (de)	2005-10-11	2011-02-10	Intermune Inc	Verbindungen und verfahren zur inhibierung der replikation des hepatitis-c-virus
US7741281B2 (en)	2005-11-03	2010-06-22	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
RU2008152171A (ru)	2006-07-05	2010-08-10	Интермьюн, Инк. (Us)	Новые ингибиторы вирусной репликации гепатита с
US7935670B2 (en)	2006-07-11	2011-05-03	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
EA017448B1 (ru)	2006-07-13	2012-12-28	Ачиллион Фармасьютикалз, Инк.	4-амино-4-оксобутаноиловые пептиды как ингибиторы вирусной репликации
US8343477B2 (en)	2006-11-01	2013-01-01	Bristol-Myers Squibb Company	Inhibitors of hepatitis C virus
US7772180B2 (en)	2006-11-09	2010-08-10	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US7888464B2 (en)	2006-11-16	2011-02-15	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US7763584B2 (en)	2006-11-16	2010-07-27	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8003604B2 (en)	2006-11-16	2011-08-23	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
AR064258A1 (es) *	2006-11-17	2009-03-25	Tibotec Pharm Ltd	Inhibidores macrociclicos del virus de hepatitis c
SI2121674T1 (sl) *	2007-02-01	2010-09-30	Tibotec Pharm Ltd	Postopki in intermediati za pripravo makrocikličnega proteaznega inhibitorja HCV
JP5554569B2 (ja) *	2007-02-08	2014-07-23	ヤンセン・アールアンドデイ・アイルランド	ピリミジン置換された大環状ｈｃｖ阻害剤
ITMI20071616A1 (it)	2007-08-03	2009-02-04	Cosmo Spa	Processo enzimatico per l'ottenimento di 17-alfa monoesteri del cortexolone e/o suoi 9,11-deidroderivati.
CA2700383A1 (en) *	2007-09-24	2009-04-02	Achillion Pharmaceuticals, Inc.	Urea-containing peptides as inhibitors of viral replication
US8383583B2 (en)	2007-10-26	2013-02-26	Enanta Pharmaceuticals, Inc.	Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors
US8426360B2 (en) *	2007-11-13	2013-04-23	Enanta Pharmaceuticals, Inc.	Carbocyclic oxime hepatitis C virus serine protease inhibitors
US8263549B2 (en)	2007-11-29	2012-09-11	Enanta Pharmaceuticals, Inc.	C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors
US8202996B2 (en)	2007-12-21	2012-06-19	Bristol-Myers Squibb Company	Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
JPWO2009084695A1 (ja)	2007-12-28	2011-05-19	カルナバイオサイエンス株式会社	２−アミノキナゾリン誘導体
WO2009117594A1 (en)	2008-03-20	2009-09-24	Enanta Pharmaceuticals, Inc.	Fluorinated macrocyclic compounds as hepatitis c virus inhibitors
US8163921B2 (en)	2008-04-16	2012-04-24	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
JP5529120B2 (ja)	2008-05-29	2014-06-25	ブリストル−マイヤーズスクイブカンパニー	Ｃ型肝炎ウイルス阻害剤
US7964560B2 (en)	2008-05-29	2011-06-21	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8207341B2 (en)	2008-09-04	2012-06-26	Bristol-Myers Squibb Company	Process or synthesizing substituted isoquinolines
UY32099A (es) *	2008-09-11	2010-04-30	Enanta Pharm Inc	Inhibidores macrocíclicos de serina proteasas de hepatitis c
US8044087B2 (en)	2008-09-29	2011-10-25	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8563505B2 (en)	2008-09-29	2013-10-22	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
JP5723783B2 (ja)	2008-12-10	2015-05-27	アキリオンファーマシューティカルズ，インコーポレーテッド	ウイルス複製の阻害剤としての新しい４−アミノ−４−オキソブタノイルペプチド
US8283310B2 (en)	2008-12-15	2012-10-09	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
JP5711672B2 (ja)	2009-02-27	2015-05-07	ジヤンセン・フアーマシユーチカルズ・インコーポレーテツドＪａｎｓｓｅｎＰｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ．	Ｈｃｖの大環状阻害剤の無定形塩
EP2417134B1 (de)	2009-04-08	2017-05-17	Idenix Pharmaceuticals LLC.	Macrocyclische serinproteaseinhibitoren
CA2762347A1 (en) *	2009-05-29	2010-12-02	Syngenta Participations Ag	Substituted quinazolines as fungicides
AR077712A1 (es)	2009-08-05	2011-09-14	Idenix Pharmaceuticals Inc	Inhibidores de serina proteasa macrociclica
US8937041B2 (en)	2010-12-30	2015-01-20	Abbvie, Inc.	Macrocyclic hepatitis C serine protease inhibitors
MX2013007698A (es)	2010-12-30	2013-08-15	Abbvie Inc	Inhibidores de serina proteasa de hepatitis c macrociclicos de fenantridina.
US9353100B2 (en)	2011-02-10	2016-05-31	Idenix Pharmaceuticals Llc	Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
US8957203B2 (en)	2011-05-05	2015-02-17	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US10201584B1 (en)	2011-05-17	2019-02-12	Abbvie Inc.	Compositions and methods for treating HCV
US8691757B2 (en)	2011-06-15	2014-04-08	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
AU2012360905B2 (en)	2011-12-28	2017-04-27	Janssen Sciences Ireland Uc	Hetero-bicyclic derivatives as HCV inhibitors
BR112015008171B1 (pt) *	2012-10-15	2021-01-19	Albemarle Corporation	processos para a síntese de 2-amino-4,6-dimetoxibenzamida e de outros compostos de benzamida
WO2014062196A1 (en)	2012-10-19	2014-04-24	Bristol-Myers Squibb Company	Hepatitis c virus inhibitors
EP2914598B1 (de)	2012-11-02	2017-10-18	Bristol-Myers Squibb Company	Inhibitoren des hepatitis-c-virus
WO2014070964A1 (en)	2012-11-02	2014-05-08	Bristol-Myers Squibb Company	Hepatitis c virus inhibitors
US9643999B2 (en)	2012-11-02	2017-05-09	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
EP2914614B1 (de)	2012-11-05	2017-08-16	Bristol-Myers Squibb Company	Inhibitoren des hepatitis-c-virus
US9580463B2 (en)	2013-03-07	2017-02-28	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
WO2014145600A1 (en)	2013-03-15	2014-09-18	Achillion Pharmaceuticals, Inc.	Ach-0142684 sodium salt polymorphs, composition including the same, and method of manufacture thereof
WO2014145507A1 (en)	2013-03-15	2014-09-18	Achillion Pharmaceuticals, Inc.	A process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
EP3089757A1 (de)	2014-01-03	2016-11-09	AbbVie Inc.	Feste antivirale darreichungsformen
EP3108879A1 (de)	2015-06-25	2016-12-28	Cassiopea S.p.A.	Hochkonzentrierte formulierung

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6323180B1 (en)	1998-08-10	2001-11-27	Boehringer Ingelheim (Canada) Ltd	Hepatitis C inhibitor tri-peptides
UA74546C2 (en)	1999-04-06	2006-01-16	Boehringer Ingelheim Ca Ltd	Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
US6867185B2 (en) *	2001-12-20	2005-03-15	Bristol-Myers Squibb Company	Inhibitors of hepatitis C virus
AU2003223602B8 (en)	2002-04-11	2010-05-27	Vertex Pharmaceuticals Incorporated	Inhibitors of serine proteases, particularly hepatitis C virus NS3-NS4 protease
MY140680A (en)	2002-05-20	2010-01-15	Bristol Myers Squibb Co	Hepatitis c virus inhibitors
US20050075279A1 (en) *	2002-10-25	2005-04-07	Boehringer Ingelheim International Gmbh	Macrocyclic peptides active against the hepatitis C virus
WO2004072243A2 (en) *	2003-02-07	2004-08-26	Enanta Pharmaceuticals, Inc.	Macrocyclic hepatitis c serine protease inhibitors
US20040180815A1 (en) *	2003-03-07	2004-09-16	Suanne Nakajima	Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
WO2004094452A2 (en) *	2003-04-16	2004-11-04	Bristol-Myers Squibb Company	Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus
US7125845B2 (en) *	2003-07-03	2006-10-24	Enanta Pharmaceuticals, Inc.	Aza-peptide macrocyclic hepatitis C serine protease inhibitors
MXPA06003141A (es) *	2003-09-22	2006-06-05	Boehringer Ingelheim Int	Peptidos macrociclicos activos contra el virus de la hepatitis c.
EA014584B1 (ru) *	2004-01-30	2010-12-30	Медивир Аб	Ингибиторы ns-3 сериновой протеазы hcv
PE20070211A1 (es) *	2005-07-29	2007-05-12	Medivir Ab	Compuestos macrociclicos como inhibidores del virus de hepatitis c
ES2456617T3 (es) *	2005-07-29	2014-04-23	Janssen R&D Ireland	Inhibidores macrocíclicos del virus de la hepatitis C
JP2009502845A (ja) *	2005-07-29	2009-01-29	メディヴィル・アクチボラグ	Ｃ型肝炎ウイルスの大環状インヒビター
AR055105A1 (es) *	2005-07-29	2007-08-08	Tibotec Pharm Ltd	Inhibidores macrociclicos del virus de la hepatitis c

2006
- 2006-07-26 PE PE2006000903A patent/PE20070343A1/es not_active Application Discontinuation
- 2006-07-28 TW TW095127585A patent/TWI387597B/zh not_active IP Right Cessation
- 2006-07-28 GT GT200600343A patent/GT200600343A/es unknown
- 2006-07-28 RS RSP-2010/0183A patent/RS51227B/sr unknown
- 2006-07-28 DK DK06764268.6T patent/DK1912981T3/da active
- 2006-07-28 PL PL06764268T patent/PL1912981T3/pl unknown
- 2006-07-28 AR ARP060103303A patent/AR057702A1/es not_active Application Discontinuation
- 2006-07-28 JP JP2008523383A patent/JP5230418B2/ja not_active Expired - Fee Related
- 2006-07-28 AP AP2008004306A patent/AP2585A/xx active
- 2006-07-28 ME MEP-2012-119A patent/ME01454B/me unknown
- 2006-07-28 KR KR1020087004894A patent/KR101083631B1/ko not_active IP Right Cessation
- 2006-07-28 EA EA200800482A patent/EA014188B1/ru not_active IP Right Cessation
- 2006-07-28 AU AU2006274866A patent/AU2006274866B2/en not_active Ceased
- 2006-07-28 PT PT06764268T patent/PT1912981E/pt unknown
- 2006-07-28 AT AT06764268T patent/ATE455775T1/de active
- 2006-07-28 US US11/995,900 patent/US7659245B2/en not_active Expired - Fee Related
- 2006-07-28 MY MYPI20063670 patent/MY151026A/en unknown
- 2006-07-28 NZ NZ564540A patent/NZ564540A/en not_active IP Right Cessation
- 2006-07-28 EP EP06764268A patent/EP1912981B1/de active Active
- 2006-07-28 WO PCT/EP2006/064822 patent/WO2007014927A2/en active Application Filing
- 2006-07-28 SI SI200630627T patent/SI1912981T1/sl unknown
- 2006-07-28 ES ES06764268T patent/ES2339702T3/es active Active
- 2006-07-28 UY UY29704A patent/UY29704A1/es unknown
- 2006-07-28 DE DE602006011905T patent/DE602006011905D1/de active Active
- 2006-07-28 BR BRPI0614153-6A patent/BRPI0614153A2/pt not_active Application Discontinuation
- 2006-07-28 CA CA2617103A patent/CA2617103C/en not_active Expired - Fee Related
- 2006-07-29 SV SV2006002641A patent/SV2008002641A/es unknown
2007
- 2007-12-20 IL IL188320A patent/IL188320A/en not_active IP Right Cessation
2008
- 2008-02-29 NO NO20081075A patent/NO20081075L/no not_active Application Discontinuation
- 2008-06-20 HK HK08106903.5A patent/HK1116488A1/xx not_active IP Right Cessation
2010
- 2010-04-14 HR HR20100209T patent/HRP20100209T1/hr unknown
- 2010-04-20 CY CY20101100355T patent/CY1110008T1/el unknown

Also Published As

Publication number	Publication date
SI1912981T1 (sl)	2010-05-31
HK1116488A1 (en)	2008-12-24
CY1110008T1 (el)	2015-01-14
KR101083631B1 (ko)	2011-11-16
WO2007014927A2 (en)	2007-02-08
EP1912981B1 (de)	2010-01-20
AP2585A (en)	2013-02-04
IL188320A0 (en)	2008-04-13
AU2006274866B2 (en)	2012-04-12
DK1912981T3 (da)	2010-05-25
TWI387597B (zh)	2013-03-01
JP5230418B2 (ja)	2013-07-10
IL188320A (en)	2014-07-31
AR057702A1 (es)	2007-12-12
RS51227B (sr)	2010-12-31
TW200745116A (en)	2007-12-16
AU2006274866A1 (en)	2007-02-08
SV2008002641A (es)	2008-07-23
PE20070343A1 (es)	2007-05-12
CA2617103A1 (en)	2007-02-08
PL1912981T3 (pl)	2010-07-30
WO2007014927A3 (en)	2007-11-29
MY151026A (en)	2014-03-31
HRP20100209T1 (hr)	2010-05-31
NZ564540A (en)	2010-03-26
GT200600343A (es)	2007-08-06
UY29704A1 (es)	2007-05-31
US20090118312A1 (en)	2009-05-07
EA014188B1 (ru)	2010-10-29
US7659245B2 (en)	2010-02-09
BRPI0614153A2 (pt)	2011-03-15
KR20080033475A (ko)	2008-04-16
EA200800482A1 (ru)	2008-06-30
PT1912981E (pt)	2010-04-16
ME01454B (me)	2014-04-20
EP1912981A2 (de)	2008-04-23
JP2009502890A (ja)	2009-01-29
DE602006011905D1 (de)	2010-03-11
CA2617103C (en)	2015-01-06
NO20081075L (no)	2008-04-25
ES2339702T3 (es)	2010-05-24

Publication	Publication Date	Title
ATE524475T1 (de)	2011-09-15	Makrocyclische inhibitoren des hepatitis-c-virus
ATE496908T1 (de)	2011-02-15	Makrocyclische inhibitoren des hepatitis-c-virus
ATE455775T1 (de)	2010-02-15	Makrocyclische inhibitoren des hepatitis-c-virus
ATE517902T1 (de)	2011-08-15	Makrocyclische inhibitoren des hepatitis-c-virus
ATE496042T1 (de)	2011-02-15	Makrocyclische inhibitoren des hepatitis-c-virus
ATE496934T1 (de)	2011-02-15	Makrocyclische inhibitoren des hepatitis-c-virus
CY2014044I1 (el)	2016-04-13	Μακροκυκλικοι αναστολεις του ιου της ηπατιτιδας c
DK1912996T3 (da)	2012-09-17	Makrocykliske inhibitorer af hepatitis C-virus
PL1919904T3 (pl)	2014-06-30	Makrocykliczne inhibitory wirusa zapalenia wątroby typu C
SI1913015T1 (sl)	2014-05-30	Makrociklični inhibitorji virusa Hepatitis C
ZA200800859B (en)	2009-06-24	Macrocyclic inhibitors of hepatitis C virus
ZA200800856B (en)	2009-06-24	Macrocyclic inhibitors of hepatitis C virus

Legal Events

Date	Code	Title	Description
2010-08-15	UEP	Publication of translation of european patent specification	Ref document number: 1912981 Country of ref document: EP

Date

Code

Title

Description

2010-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1912981

Country of ref document: EP